Safety risks grow as compounded GLP-1 weight-loss drugs expand in unregulated market

The rise of compounded GLP-1 medicines offers a cheaper option for weight-loss, but safety concerns are mounting due to lack of regulation, dosing errors, and quality issues, prompting calls for stricter oversight and informed patient choices. Compounded GLP-1 medicines have…













